Growth • Elanco Animal Health
ELAN
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
7,6%
CAGR Revenue 5Y
Revenue Compound Annual Growth Rate in the last 5 years.
-7,5%
CAGR Op. Income 5Y
Operating Income Compound Annual Growth Rate in the last 5 years.
37,9%
CAGR Net Income 5Y
Net Income Compound Annual Growth Rate in the last 5 years.
30,5%
CAGR EPS 5Y
Earnings Per Share Compound Annual Growth Rate in the last 5 years.
-81,6%
CAGR Normalized EPS 5Y
Normalized Earnings Per Share Compound Annual Growth Rate in the last 5 years.
19,3%
CAGR OCF 5Y
Cash Flow from Operating activities Compound Annual Growth Rate in the last 5 years.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!